La Verde Nicla, Collovà Elena, Lonardi Sara, Generali Daniele, Moretti Anna, Atzori Francesco, Cazzaniga Marina, Saggia Chiara, Tondulli Luca, Marcon Ilaria, Gentile Anna Lisa, Rossello Rosalba, Martelli Olga, Aglione Stefania, Farina Gabriella, Cinquini Michela, Garassino Marina
Tumori. 2013 Sep-Oct;99(5):596-600. doi: 10.1177/030089161309900506.
We report a collection of data about early breast cancer in male patients from 13 Italian institutions.
We obtained data from patient charts and performed statistical analysis. The primary end points were overall survival and disease-free survival.
A total of 205 men with invasive breast cancer was identified, with a median age of 66 years. Pathological characteristics were heterogeneous for T stage, N stage and HER2 status. Histological subtype was predominantly ductal infiltrating carcinoma. Most of them were hormone receptor positive. Mastectomy was the most common strategy. Postsurgical treatment was not standardized. Patients with large tumors were more likely to be treated with chemotherapy. Disease recurrence was associated with an ER+ and PR+ status.
We identified a correlation between relapse and hormone receptor expression, as is the case in female breast cancer.
我们报告了来自13家意大利机构的男性早期乳腺癌患者的数据集。
我们从患者病历中获取数据并进行统计分析。主要终点为总生存期和无病生存期。
共识别出205例浸润性乳腺癌男性患者,中位年龄为66岁。T分期、N分期和HER2状态的病理特征存在异质性。组织学亚型主要为导管浸润癌。大多数患者激素受体呈阳性。乳房切除术是最常见的治疗策略。术后治疗不规范。肿瘤较大的患者更有可能接受化疗。疾病复发与雌激素受体(ER)阳性和孕激素受体(PR)阳性状态相关。
正如女性乳腺癌一样,我们发现复发与激素受体表达之间存在相关性。